• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Benefit of Prompt Versus Delayed Initiation of Single-Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the US

home / publications / supplement / benefit-of-prompt-vs-delayed-initiation-of-trelegy-ellipta-fluticasone-furoate-umeclidinium-and-
© 2023 MJH Life Sciences
All rights reserved.